5 verified backers on Rhygaze's cap table, including GV, ARCH Venture Partners, F-Prime Capital — Biotech (Basel, Switzerland).
Rhygaze's investor syndicate for 2026, drawn from verified round records: 5 distinct firms and angels appear on the cap table, including GV, ARCH Venture Partners, F-Prime Capital, BioGeneration Ventures, Novartis Venture Fund. Rhygaze is tracked in Biotech and headquartered in Basel, Switzerland.
The companies listed below are ranked by how much of that syndicate they share, so the overlap you see is backer-based rather than sector-based. Every investor name links to that firm's own profile with its full tracked portfolio, and every company links to its funding record.